Document is current
Any future updates will be listed below
-
Authors
Raymond, Kimberly https://orcid.org/0000-0001-9096-9269
Chen, Wen-Hung https://orcid.org/0000-0002-6610-9709
Bracher, Marguerite https://orcid.org/0000-0001-9423-6097
Foster, April https://orcid.org/0000-0002-9663-7510
Lovley, Andrew https://orcid.org/0000-0001-9118-0673
Saucier, Cory https://orcid.org/0000-0002-0420-6458
Jackson, Kristi https://orcid.org/0000-0003-0081-5165
McDermott, Eleanor J. https://orcid.org/0000-0001-6302-4171
-
Funding
Funding for this research was provided by:
GlaxoSmithKline
- License Information
-
More Information
Article History
Accepted: 21 September 2023
First Online: 27 October 2023
Declarations
:
: Wen-Hung Chen, Marguerite Bracher, and Eleanor J. McDermott are employees of, and/or hold stocks and shares in, GSK. Kimberly Raymond, April Foster, Andrew Lovley, Cory Saucier, and Kristi Jackson are employees of QualityMetric Inc; QualityMetric Inc received funding from GSK to conduct the study.
: Approval was obtained from the New England Independent Review Board in the US. The project was conducted according to the principles outlined in the declaration of Helsinki and in line with guidelines related to Good Clinical Practice published by the U.S. Food & Drug Administration, where applicable to non-interventional research.
: Informed consent was obtained from all individual participants included in the study.
: Not applicable.
